An Open-label, Randomized, Crossover, Reader-blinded Study to Investigate the Effect of Prucalopride and Polyethylene Glycol 3350 on Colon Motility With Intramural Manometry in Subjects With Chronic Constipation

Trial Profile

An Open-label, Randomized, Crossover, Reader-blinded Study to Investigate the Effect of Prucalopride and Polyethylene Glycol 3350 on Colon Motility With Intramural Manometry in Subjects With Chronic Constipation

Completed
Phase of Trial: Phase IV

Latest Information Update: 29 Nov 2014

At a glance

  • Drugs Prucalopride (Primary) ; PEG-3350/sodium chloride/sodium bicarbonate/potassium chloride
  • Indications Constipation
  • Focus Pharmacodynamics
  • Sponsors Shire; Shire-Movetis NV
  • Most Recent Events

    • 01 Dec 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 24 Oct 2013 Planned End Date changed from 1 Oct 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.
    • 25 Apr 2013 Planned end date changed from 1 Jun 2013 to 1 Oct 2013 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top